Showing results (1-10 of 233) with videos related to

Sort By:
Pageof 24
Annales Pharmaceutiques Francaises|January 12, 2015
[Fecal microbiota transplantation: review]F Barbut, A Collignon, M-J Butel, et al.
Annales Pharmaceutiques Francaises|September 16, 2014
[Why could gut microbiota become a medication?]P Bourlioux, F Megerlin, G Corthier, et al.
Canadian Journal of Microbiology|April 17, 1998
Protease activity of Clostridium difficile strainsI Poilane, T Karjalainen, M C Barc, et al.
Applied and Environmental Microbiology|September 3, 1999
Clostridium difficile cell attachment is modified by environmental factorsA J Waligora, M C Barc, P Bourlioux, et al.
Annales Pharmaceutiques Francaises|April 1, 2015
[Fecal microbiota transplantation in recurrent Clostridium difficile infections. Framework and pharmaceutical preparation aspects]R Batista, N Kapel, F Megerlin, et al.
Infection and Immunity|March 20, 2001
Characterization of a cell surface protein of Clostridium difficile with adhesive propertiesA J Waligora, C Hennequin, P Mullany, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1992
Effects of antibiotics and other drugs on toxin production in Clostridium difficile in vitro and in vivoM C Barc, C Depitre, G Corthier, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1995
Value of routine stool cultures in hospitalized patients with diarrheaF Barbut, P Leluan, G Antoniotti, et al.
Microbiology (Reading, England)|February 13, 2001
GroEL (Hsp60) of Clostridium difficile is involved in cell adherenceC Hennequin, F Porcheray, A Waligora-Dupriet, et al.
Journal of Clinical Microbiology|September 2, 2000
Phenotypic and genotypic diversity of the flagellin gene (fliC) among Clostridium difficile isolates from different serogroupsA Tasteyre, T Karjalainen, V Avesani, et al.
Pageof 24